Biocytogen Launches AI-Powered RenSuper Platform to Accelerate Therapeutic Antibody Discovery
Biocytogen unveils RenSuper, a next-generation AI-driven antibody discovery and automation platform designed to streamline therapeutic biologics development and accelerate the delivery of innovative medicines worldwide.
Drug Discovery Technology | 28/05/2026 | By News Bureau | 138
Incyte and Genesis Molecular AI have expanded their strategic collaboration to deploy advanced molecular AI technologies and proprietary research data, aiming to accelerate drug discovery and develop next-generation therapies through AI-powered molecular design.
Drug Discovery Technology | 22/05/2026 | By News Bureau | 247
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy